- Citations, last 5 years
- 6
- Works, last 5 years
- 3
- h-index
- 22
- Scientists listed
- 1
- Grants since 2016
- 5
Grants received
2022–2024 · research · R44
Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 018569
Joan Marie Robbins · DNAtrix (United States) · funded by National Institutes of Health
2016–2020 · research · R01
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)
Frank Tufaro · DNAtrix (United States) · funded by U.S. Food and Drug Administration
2016–2020 · research · R01
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)
Frank Tufaro · DNAtrix (United States) · funded by U.S. Food and Drug Administration
2016–2020 · research · R01
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)
Matteo G Levisetti · DNAtrix (United States) · funded by U.S. Food and Drug Administration
2016–2020 · research · R01
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)
Frank Tufaro · DNAtrix (United States) · funded by U.S. Food and Drug Administration
